Corgenix shareholders OK acquisition

BROOMFIELD – Shareholders of Corgenix Medical Corp., which is working on a rapid diagnostic test for Ebola, on Wednesday approved the acquisition of the Broomfield-based developer and marketer of diagnostic test kits by a German company.

The board of directors of Corgenix (OTC QB: CONX.OB) had agreed unanimously in August that the company could be acquired by Orgentec Diagnostika, a specialty diagnostics company headquartered in Mainz, Germany.

The shareholders’ vote to approve the acquisition was 30,121,029 shares in favor to 10,317,317 shares opposed and 16,953 abstentions, according to a Form 8-K filing with the federal Securities and Exchange Commission.

Under the terms of…